This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/drugbank/drug/DB02388/identifier/pdb/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02388/identifier/bindingdb/
n15http://linked.opendata.cz/resource/drugbank/drug/DB02388/identifier/pubchem-compound/
n4http://linked.opendata.cz/resource/drugbank/drug/DB02388/identifier/pubchem-substance/
n14http://bio2rdf.org/drugbank:
n5http://linked.opendata.cz/resource/drugbank/drug/DB02388/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n7http://linked.opendata.cz/ontology/drugbank/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02388/identifier/chemspider/
n8http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02388
rdf:type
n7:Drug
n7:group
experimental
owl:sameAs
n13:DB02388 n14:DB02388
dcterms:title
Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine
adms:identifier
n4:46504625 n5:DB02388 n6:880 n10:16016 n11:394842 n15:447873
n7:IUPAC-Name
n8:271B593A-363D-11E5-9242-09173F13E4C5
n7:InChI
n8:271B5940-363D-11E5-9242-09173F13E4C5
n7:Molecular-Formula
n8:271B593F-363D-11E5-9242-09173F13E4C5
n7:Molecular-Weight
n8:271B593C-363D-11E5-9242-09173F13E4C5
n7:Monoisotopic-Weight
n8:271B593D-363D-11E5-9242-09173F13E4C5
n7:SMILES
n8:271B593E-363D-11E5-9242-09173F13E4C5
n7:Water-Solubility
n8:271B5938-363D-11E5-9242-09173F13E4C5
n7:logP
n8:271B5936-363D-11E5-9242-09173F13E4C5 n8:271B5939-363D-11E5-9242-09173F13E4C5
n7:logS
n8:271B5937-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Acceptor-Count
n8:271B5946-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Donor-Count
n8:271B5947-363D-11E5-9242-09173F13E4C5
n7:InChIKey
n8:271B5941-363D-11E5-9242-09173F13E4C5
n7:Polar-Surface-Area--PSA-
n8:271B5942-363D-11E5-9242-09173F13E4C5
n7:Polarizability
n8:271B5944-363D-11E5-9242-09173F13E4C5
n7:Refractivity
n8:271B5943-363D-11E5-9242-09173F13E4C5
n7:Rotatable-Bond-Count
n8:271B5945-363D-11E5-9242-09173F13E4C5
n7:Bioavailability
n8:271B594C-363D-11E5-9242-09173F13E4C5
n7:Ghose-Filter
n8:271B594E-363D-11E5-9242-09173F13E4C5
n7:MDDR-Like-Rule
n8:271B594F-363D-11E5-9242-09173F13E4C5
n7:Number-of-Rings
n8:271B594B-363D-11E5-9242-09173F13E4C5
n7:Physiological-Charge
n8:271B594A-363D-11E5-9242-09173F13E4C5
n7:Rule-of-Five
n8:271B594D-363D-11E5-9242-09173F13E4C5
n7:Traditional-IUPAC-Name
n8:271B593B-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-acidic-
n8:271B5948-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-basic-
n8:271B5949-363D-11E5-9242-09173F13E4C5